F 0578
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Honor the resident's right to request, refuse, and/or discontinue treatment, to participate in or refuse to
participate in experimental research, and to formulate an advance directive.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure an advance directive (AD, a written instruction, such
as a living will or durable power of attorney for health care for when the individual becomes incapacitated)
or Physician Orders for Life-Sustaining Treatment (POLST, document that specifies the medical treatments
the resident wants to receive during serious illness) was completed for 3 of 31 sampled residents
(Residents 29, 31, and 32). These failures could lead to the delivery of unnecessary or inappropriate
medical services, which are against the residents' goals and wishes.
Findings:
Review of Resident 29's clinical record indicated he was initially admitted to the facility on [DATE]. Review
of Resident 29's POLST form, dated 8/20/24, indicated the AD section of the POLST form was blank. The
POLST form did not indicate if there was an advance directive in placed or it was not available. Further
review of Resident 29's POLST form indicated the section titled Artificially Administered Nutrition was
blank. The POLST form did not indicate Resident 29's choices regarding feeding tubes and artificial
nutrition.
Review of Resident 31's clinical record indicated she was initially admitted to the facility on [DATE]. Review
of Resident 31's POLST form, dated 11/28/23, indicated the AD section of the POLST form was blank. The
POLST form did not indicate if there was an advance directive in placed or it was not available.
Review of Resident 32's clinical record indicated she was initially admitted to the facility on [DATE]. Review
of Resident 32's POLST form, dated 8/7/24, indicated the AD section of the POLST form was blank. The
POLST form did not indicate if there was an advance directive in placed or it was not available.
During an interview and concurrent record review with the director of nursing (DON) on 1/17/25 at 12:01
p.m., the DON reviewed the POLST forms for Residents 29, 31, and 32. She stated the admission nurse
reviews the POLST form with the resident or their responsible party (RP) and discusses their wishes
regarding medical treatment. The DON confirmed The POLST forms for Residents 29, 31, and 32 were
incomplete. The DON stated all sections of the POLST forms should be completed and signed by the
physician and the resident or their RP.
A review of the facility's policy titled Advance Directives, revised 9/2022, indicated the advanced directives
would be honored in accordance with state and facility policy. Upon admission, the resident would be
provided with written information concerning the right to refuse or accept medical or
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 18
Event ID:
056212
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0578
surgical treatment and to formulate an advance directive if he or she chooses to do so.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 2 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to develop and implement a comprehensive,
resident-centered care plan for one out of eleven sampled residents, (Resident 301), when Resident 301's
refusals to participate in the activities that were being offered was not care planned.
This failure had the potential to result in the resident not receiving the intervention and monitoring
necessary to maintain his highest level of well-being.
Findings:
During a concurrent observation and interview of Resident 301 on 1/14/25 at 9:30 a.m., Resident 301 was
laying in his bed, alert, calm and verbally responsive. He was refusing to participate in activities.
During another concurrent observation and interview of Resident 301 on 1/15/25 at 8:50 a.m., Resident
301 was in his bed and appeared calm and comfortable. He was still refusing to participate in activities.
Review of Resident 301's admission record (document that contains information about a resident's
admission to a healthcare facility) indicated, Resident 301 was readmitted to the facility on [DATE] with
diagnoses including unspecified parkinsonism (group of neurodegenerative conditions that manifest with
motor symptoms, including rigidity, tremors and bradykinesia), unspecified schizoaffective disorder (mental
health condition that includes symptoms of both schizophrenia and mood disorders) and generalized
muscle weakness (decreased strength in the muscles).
Review of Resident 301's order listing report (list of orders for a resident, including the details of each
order) indicated, Resident 301 may participate in activity program if not in conflict with treatment plan,
revised on 12/27/24.
During an interview with the activity assistant I (AA I) on 1/17/25 at 9:35 a.m., AA I verified that the resident
refused to participate in activities and there was no care plan about his refusal to participate in activities
and this behavior was not monitored and followed up.
During a concurrent record review of Resident 301's care plans and interview with the assistant director of
nursing A (ADON A) on 1/17/25 at 12:31 p.m., ADON A verified that there was no care plan of Resident
301's refusal to participate in activities and this behavior of refusing to participate in activities should have
been care planned, monitored and followed up.
During an interview with the director of nursing (DON) on 1/17/25 at 12:55 p.m., DON verified that Resident
301's refusal to participate in activities should have been care planned, monitored and followed up.
Review of the facility's policy and procedure titled, Care Plans, Comprehensive Person-Centered, revised
March 2022, indicated, A comprehensive, person-centered care plan that includes measurable objectives
and timetables to meet the resident's physical, psychosocial and functional needs is developed and
implemented for each resident . The comprehensive, person-centered care plan . reflects
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 3 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
currently recognized standards of practice for problem areas and conditions . Assessments of residents are
ongoing and care plans are revised as information about the residents and the residents' condition change .
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 4 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to provide care in accordance with professional
standards of practice for two of thirty-one sampled residents, (Residents 8 and 400), when:
Residents Affected - Few
1. for Resident 8, there was no care plan, monitoring and follow-up of her hand contractures, and
2. for Resident 400, the staff took the blood pressure (BP, the force of blood pushing against the walls of the
arteries) on the same arm where the resident has the AV fistula (arteriovenous fistula, connection that's
made between an artery and a vein for dialysis access.)
These failures had the potential for the residents, not to attain or maintain their highest practicable physical,
mental, psychosocial well-being, and potential to cause injury.
Findings:
During a concurrent observation and interview of Resident 8 on 1/14/25 at 8:45 a.m., Resident 8 was laying
in her bed, alert, calm, comfortable and verbally responsive. Resident 8's hands were contracted and she
verbalized that she's not getting therapy of her contracted hands anymore which could be very helpful.
Review of Resident 8's admission record (document that contains information about a resident's admission
to a healthcare facility) indicated, Resident 8 was admitted to the facility on [DATE] with diagnoses including
hemiplegia (complete paralysis on one side of the body) and hemiparesis (muscle weakness or partial
paralysis on one side of the body) following cerebral infarction (type of stroke that occurs when the brain
tissue dies due to lack of blood flow) affecting right dominant side, type 2 diabetes mellitus (chronic
condition characterized by high levels of sugar in the blood) with diabetic chronic kidney disease (condition
that occurs when diabetes damages the kidneys over time) and generalized muscle weakness (decreased
strength in the muscles).
Review of Resident 8's clinical records indicated that the hand contractures of Resident 8 were not care
planned, monitored and followed up.
During another concurrent observation and interview of Resident 8 with assistant director of nursing A
(ADON A) on 1/16/25 at 3:35 p.m., Resident 8 was laying in her bed, calm and comfortable. Resident 8
stated that therapy and follow-up of her hand contractures will be good for her.
During an interview with ADON A on 1/16/25 at 3:48 p.m., ADON A verified the hand contractures of
Resident 8 and stated that they should have been care planned, monitored and followed up to prevent
deterioration of the hand contractures.
During an interview with the director of nursing (DON) on 1/17/25 at 12:50 p.m., DON acknowledged that
the hand contractures of Resident 8 should have been care planned, monitored and followed-up to avoid
the hand contractures, from getting worse.
Review of the facility's policy and procedure titled, Activities of Daily Living (ADLs), revised March 2018,
indicated, Residents will be provided with care, treatment and services as appropriate to maintain or
improve their ability to carry out activities of daily living (ADLs) . Interventions to
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 5 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
improve or minimize a resident's functional abilities will be in accordance with the resident's assessed
needs, preferences, stated goals and recognized standards of practice. The resident's response to
interventions will be monitored, evaluated and revised as appropriate .
2.During a review of Resident 400's clinical record indicated, Resident 400 was admitted to the facility on
[DATE] with diagnoses including end stage renal disease (a condition in which the kidneys lose the ability to
remove waste and balance fluids.)
Review of Resident 400's admission record Inpatient Nephrology Consult Follow Up Note indicated,
Resident 400 has left AV fistula and chest permacath (a flexible tube that's inserted into a blood vessel in
the neck or chest).
During a review of Resident 400's Blood Pressure Summary indicated, Resident 400 had the blood
pressure taken on the left arm on the following dates:
1/3/2025 at 02:00;
1/3/2025 at 10:23;
1/4/2025 at 09:05;
1/5/2025 at 01:29;
1/6/2025 at 09:32;
1/7/2025 at 09:52;
1/8/2025 at 10:11;
1/10/2025 at 00:14;
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 6 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
1/102025 at 16:20;
Level of Harm - Minimal harm
or potential for actual harm
1/11/2025 at 11:16;
Residents Affected - Few
1/12/2025 at 05:29;
1/12/2025 at 08:26;
1/13/2025 at 08:34;
1/14/2025 at 08:10;
1/14/2025 at 12:45;
1/14/2025 at 22:23;
1/15/2025 at 10:13 and
1/17/2025 at 08:21.
During a concurrent interview and record review on 1/17/2025 at 11:41 a.m., with the Director of Nursing
(DON), the DON reviewed Resident 400's clinical record and she stated, Resident 400 had chest
permacath and left AV fistula. The DON confirmed, Resident 400's BP summary dated January
3,4,5,6,7,8,10,11,12,13,14,15, and 17/2025, that were recorded were taken on left arm. The DON stated
that nurses, should not check the blood pressure on the AV fistula, because it could interfere with the blood
flow.
Review of the facility's P&P titled Hemodialysis, Care of Residents, dated 11/2017, indicated, Standard . 4.
Blood pressures or venous punctures will not be performed and physical restraint will not be applied on the
extremity where access site is located.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 7 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to ensure the adequate provision of
pharmaceutical services when:
1. Three medications were not available for administration x 4 days, for one of 36 sampled residents
(Resident 311). The failure had the potential for worsening and/or complications of the resident's medical
conditions; and
2. Two of two nursing staff did not don appropriate personal protective equipment (PPE) during the
preparation and administration of hazardous drugs (HDs; medications with potential to cause cancer and/or
for causing other toxic effects on humans). The failure had the potential for staff and/or resident exposure to
dangerous medications.
Findings:
1. During a medication administration observation on 1/13/25 at 9:11 a.m., Licensed Vocational Nurse D
(LVN D) was observed administering 3 medications, including an eye drop called Cosopt 2%-0.5%
(medication to treat glaucoma) ophthalmic (eye) solution, to Resident 311.
Upon review of Resident 311's clinical record, it indicated she was admitted to the facility on [DATE] with
diagnoses including glaucoma and unspecified vision loss. The clinical record indicated the resident was to
receive 3 eye medications, as follows:
a. Cosopt ophthalmic solution 2%-0.5%, 1 drop in both eyes two times a day for glaucoma, dated 1/9/25;
b. Vyzulta ophthalmic solution (to treat increased eye pressure in adults with ocular hypertension or
open-angle glaucoma) 0.024%, 1 drop in both eyes two times a day for vision impairment, dated 1/9/25;
and
c. Xiidra ophthalmic solution (to treat signs and symptoms of dry eye disease) 5%, 1 drop in both eyes two
times a day for vision impairment, dated 1/9/25.
Resident 311 also had a physician's order for levothyroxine (medication to treat underactive thyroid gland)
75 micrograms, give 1 tablet daily in the morning for hypothyroidism, dated 1/9/25.
On 1/13/25, a review of Resident 311's January 2025 Medication Administration Record (MAR) showed the
resident had not been receiving the Vyzulta, Xiidra, and levothyroxine since 1/10/24 (or 4 days).
During an interview with LVN D and Assistant Director of Nursing B (ADON B) on 1/13/25 02:11 p.m.,
ADON B stated the Xiidra and Vyzulta were put on hold (not administered) because I was told we don't
have them available.
A review of the nursing progress notes, from 1/9/25 to 1/13/25, indicated the nursing staff did not call or
follow up with the pharmacy on the missing levothyroxine. For four consecutive days, from
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 8 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
1/10/25 to 1/13/25, the nursing staff wrote four times of Med in transit each day. For the Xiidra and Vyzulta
eye drops, there was only one nursing notes, dated 1/10/25 at 22:36 (10:36 p.m.), indicating the nursing
staff called the pharmacy and was told by a pharmacy staff that medication will arrive 1/11/25 with 5am
medication run. There were no documentation of further follow-up with the pharmacy when these
medications did not arrive on 1/11/25.
Residents Affected - Few
During a follow-up interview with ADON B on 1/14/25 at 2:21 p.m., she stated she called the pharmacy and
was told the Xiidra eye drop was not delivered because it was a high cost medication. ADON B confirmed
the pharmacy should have communicated with the facility why it did not send the medication. ADON B was
asked to find out the reason why the other two medications were not delivered.
In a concurrent interview and record review with ADON B on 1/14/25 at 3:00 p.m., ADON B stated the
facility faxed Resident 311's admission orders twice on 1/9/25 at 9:02 p.m. and again at 9:05 p.m., on the
evening the resident was admitted . However, she showed an email from the pharmacy, dated 1/14/25,
indicating: Investigation found that the 3 medications delayed til 1/13/25 were cut off on initial admit fax and
pharmacy tech missed them on initial admit papers as a result . ADON B confirmed the facility staff should
have followed up with the pharmacy each day they did not receive the medications for the resident. She
also confirmed the 3 medications did not arrive until the afternoon of 1/13/25 (day of survey), and the
resident did not receive them for 4 days.
A review of the facility's policy and procedures (P&P) titled Pharmacy Services Overview, dated 4/2019,
indicated: The facility shall accurately and safely . obtain pharmaceutical services, including the provision of
routine and emergency medications . Residents have sufficient supply of the prescribed medications and
receive medications .in a timely manner . Nursing staff communicate prescriber orders to the pharmacy and
are responsible for contacting the pharmacy if a resident's medication is not available for administration.
2. During a medication administration observation with LVN D on 1/13/25 at 9:11 a.m., the 3 medications
administered to Resident 311 included two tablets of megestrol (an anti-cancer medication that can also be
used for loss of appetite) 40 milligrams (mg, unit of measurement). During the preparation, LVN D was
observed punching 2 megestrol tablets from the blister pack (a card that packages doses of medication
within small, clear plastic bubbles [or blisters]) into a small medication cup. Then she transferred them into a
small plastic bag and crushed them into a fine powder using the crushing device. After finished, she
transferred the crushed powder back into the medication cup and mixed it with applesauce. Observation of
the pharmacy label revealed a dark red auxiliary label indicating: HAZARDOUS DRUGS. During this
preparation process, LVN D did not wear gloves or had any special PPE.
On 1/13/25 at 9:19 a.m., LVN D administered the medications to the resident with water.
During an interview, on 1/13/25 at 9:29 a.m., when shown HAZARDOUS DRUGS sticker on the pharmacy
label for megestrol tablets, LVN D stated she did not know if there was any special handling and
administration procedures for HDs.
During a follow-up interview on 1/13/25 at 11:17 a.m., LVN D stated she was supposed to wear gloves
during handling and preparing HDs.
During a medication administration observation with LVN J on 1/13/25 at 4:26 p.m., she was observed
preparing and administering 3 medications, including 3 tablets of divalproex (medication to treat
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 9 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
seizure or mood disorders) delayed release 125 mg, to Resident 25. The same dark red HAZARDOUS
DRUGS sticker was affixed by the pharmacy label of the divalproex blister pack. LVN J did not wear gloves
or had any special PPE for this preparation and administration.
Shortly after the medication administration, on 1/13/25 at 4:37 p.m., when asked whether she should have
worn special PPE when handling HDs, LVN J stated she did not know and I will need to ask the supervisor.
During an interview with ADON B on 1/13/25 at 4:42 p.m., in the presence of LVN J, ADON B stated nurses
should be wearing gloves when handling HDs.
During an interview with the DON on 01/14/25 at 1:45 p.m., she stated the consultant pharmacist had given
an in-service last year regarding handling and administering HDs. She stated, for HDs, The staff should
handle more carefully by not touching them and wearing gloves during handling and administration.
A review of the facility's P&P titled Policies and Procedures for the Safe handling of Hazardous Drugs,
dated 10/3/2019, indicated, Hazardous Drugs may have special handling procedures in place that must be
adhered to by all nursing staff that receive, handle, prepare, administer and destroy the HDs. It is the
responsibility of all staff to know these procedures . and adhere to these policies and procedures when
handling HD and Appropriate PPE must be worn when handling HDs including during . handling .
preparation/mechanical manipulation . administration .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 10 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review, the facility failed to ensure one of 31 sampled residents (Resident
400) was free from unnecessary medications when there was no monitoring for signs and symptoms of
bleeding while Resident 400 was receiving two medications with increased risk for bleeding: apixaban(an
anticoagulant or blood thinner, to prevent blood clots) and clopidogrel (an antiplatelet medication which has
potential to increase the risk of internal bleeding or gastrointestinal hemorrhaging). The failure resulted in
inadequate monitoring, and had the potential for untimely recognition and intervention for adverse effects
related to these medications.
Residents Affected - Few
Findings:
A review of Resident 400's clinical record indicated she was admitted to the facility with diagnoses including
atrial fibrillation (an irregular and often very rapid heart rhythm, a condition that can lead to blood clots in
the heart) and percutaneous coronary Intervention (PCI, a minimally invasive procedure used to open
blocked coronary [heart] arteries that are narrowed or clogged by fatty deposits).
A review of Resident 400's physician's orders included the following:
- Eliquis (apixaban) 5 milligrams (mg, unit of measurement), 1 tablet by mouth two times a day for atrial
fibrillation, dated 1/3/25; and
- Clopidogrel 75 mg, 1 tablet by mouth one time a day for PCI, dated 1/3/25.
A review of an online resource, www.drugs.com, it indicated, Using apixaban together with clopidogrel may
increase the risk of bleeding, including severe and sometimes fatal hemorrhage (accessed 1/16/25).
There was no documentation in Resident 400's clinical record indicating the nursing staff was monitoring
for adverse effects (i.e. bleeding, bruising, etc) related to the use of apixaban and clopidogrel.
A review of Resident 400's care plan, dated 1/2/25, indicated to monitor and report to the physician signs
and symptoms of anticoagulant complications: blood tinged or frank blood in urine, black tarry stools, dark
or bright red blood in stools, sudden severe headaches, nausea, vomiting, ,diarrhea, muscle joint pain,
lethargy, bruising, blurred vision, SOB, loss of appetite, sudden changes in mental status, significant or
sudden changes in v/s [vital signs].
During a concurrent interview and record review with the Director of Nursing (DON) on 1/16/25 at 2:26
p.m., she reviewed Resident 400's clinical and stated the monitoring for signs and symptoms related to
anticoagulants should be monitored on the MAR [medication administration record]. She reviewed the
resident's MAR and confirmed there was no monitoring for bleeding and other symptoms related to use of
apixaban and clopidogrel.
A review of the facility's policy and procedure titled Anticoagulant, revised 9/2017, indicated, The staff and
physician will monitor for possible complications in individuals who are being anticoagulated .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 11 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
Based on interview and record review, the facility failed to ensure three out of 31 sampled residents
(Residents 92, 307, and 400) were free from unnecessary psychotropic medications (drugs that affects
brain activities associated with mental processes and behavior) when:
1. Resident 92 received four psychotropic medications without documented evidence of attempted or
contra-indicated non-pharmacological (non-drug) interventions prior to initiating or increasing these
medications. Also, there was no monitoring for side effects of aripiprazole (Abilify, an antipsychotic
medication to treat mental illnesses) since July 2024;
2. Resident 307 received a PRN (as needed) prochlorperazine (antipsychotic medication which can be
used for short term psychotic disorders or nausea/vomiting) without a 14-day limit; and
3. Resident 400 received trazodone (an anti-depressant medication) without effectiveness monitoring.
The failures resulted in unnecessary medications for the residents, and had the potential for increased risks
associated with psychotropic medication use that include but not limited to sedation, respiratory
depression, falls, constipation, anxiety, agitation, abnormal involuntary movements, and memory loss.
Findings:
1. A review of Resident 92's clinical record indicated she was admitted to the facility in June 2024 with
diagnoses including anxiety and depression.
A review of her physician's orders indicated, on 7/3/24, she received three new psychotropic medication
orders, as follows:
a. Aripiprazole (Abilify, an antipsychotic) 5 milligrams (mg, unit of measurement), give 1 tablet by mouth one
time a day for Schizoaffective disorder Bipolar Type [a mental disorder with extreme highs (mania) and
severe lows (depression)] for 1 Week m/b [manifested by] angry outburst, demeaning staff, calling staff
names, cursing staff.
b. Cymbalta (an antidepressant) 30 mg, give 1 capsule by mouth one time a day for depression m/b
verbalization of sadness; and
c. Clonazepam (an anti-anxiety medication) 0.5 mg, give 1 tablet two times a day for ANXIETY m/b
verbalization of nervousness or expression of feeling panicky.
Also, on the same day, 7/3/24, her trazodone (an antidepressant) was increased from 50 mg to 100 mg, to
be administered at bedtime for depression m/b inability to sleep.
Despite the three new psychotropic medication orders and an increase in trazodone, there was no
documented evidence in Resident 92's clinical record of attempted or contraindicated non-drug
interventions prior to initiating and increasing these medications.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 12 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Furthermore, there was no documented evidence the facility staff monitored for the side effects of
aripiprazole since it was started.
During a concurrent interview and record review with the Director of Nursing (DON) and Assistant DON C
(ADON C) on 1/16/25 at 10:20 a.m., they reviewed Resident 92's clinical record and confirmed there had
been no monitoring for the side effects of aripiprazole. The DON stated the side effects should be
documented on the MAR but it was not there.
During a follow-up interview with the DON on 1/16/25 at 3:58 p.m., she stated the non-drug interventions
were documented only on the activity assessment and care plan but there was nothing documented to
show non-drug interventions were implemented prior to starting the medications.
2. Resident 307 was admitted to the facility with diagnoses including depression, dysphagia (swallowing
difficulties), and nasogastric (NG) tube (a small, flexible tube inserted through the nose and into the
stomach for delivery of nutrition and medications) status.
A review of Resident 307's clinical record indicated a physician's order, dated 1/6/25, for Prochlorperazine
[an antipsychotic medication] .10 mg Give 1 tablet via NG-Tube every 8 hours as needed for Nausea or
Vomiting. There was no 14-day limit to this order.
During a concurrent interview and record review with the DON on 1/16/25 at 2:22 p.m., she confirmed there
was no 14-day limit for Resident 307's prochlorperazine order.
3. A review of Resident 400's clinical record indicated she was admitted to the facility with diagnoses
including insomnia (inability to sleep). On 1/3/25, she had a physician's order for trazodone 50 mg, 1 tablet
by mouth at bedtime for insomnia m/b inability to sleep.
During an interview with Resident 400 at her bedside on 1/16/25 at 8:40 a.m., Resident 400 stated she had
not been sleeping well and would like to have stronger medication to help her sleep better.
A review of Resident 400's January 2025 MAR indicated the nursing staff had been monitoring, since
1/2/25, for inability to sleep and placing a check mark for each shift; however, there was no monitoring for
the hours of sleep (total amount of time the resident sleeps during a given period).
During a concurrent interview and record review with the DON on 1/16/25 at 2:26 p.m., she reviewed
Resident 400's MAR and stated the staff should be monitoring the hours of sleep in order to see whether
the trazodone was effective in helping the resident sleep.
A review of the facility's policy and procedures titled Psychotropic Medication Use, dated July 2022,
indicated in part:
Psychotropic medication management includes . adequate monitoring for efficacy and adverse
consequences .
Non-pharmacological approaches are used (unless contraindicated) to minimize the need for medications .
PRN orders for psychotropic medications are limited to 14 days . For psychotropic medications that ARE
antipsychotics: PRN orders cannot be renewed unless the attending physician or prescriber
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 13 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
evaluates the resident and documents the appropriateness of the medication .
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 14 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interviews, and record review, the facility had a medication error rate of 11.11%
when three medication errors occurred out of 27 opportunities during the medication administration for
three out of seven residents (Residents 81, 118, and 133). The failure resulted in the residents not receiving
the medications as prescribed, and had the potential for complications such as unnecessary pain or
medication side effects.
Residents Affected - Some
Findings:
1. During the medication administration observation on 1/13/25 at 8:41 a.m., Licensed Vocational Nurse
(LVN) D was observed preparing and administering 5 medications to Resident 81. The medications did not
include a lidocaine patch (a topical medication applied to the skin for pain management).
A review of Resident 81's clinical record indicated a physician's order, dated 11/26/24, for Lidocaine Patch
5% Apply to right shoulder topically one time a day for pain management. It was scheduled to be
administered daily at 9 a.m.
During an interview with LVN D on 1/13/25 at 2:09 p.m., she stated, We have only 4% but not 5% [patches].
We called pharmacy for delivery. She confirmed the patch was due this morning but it was not administered
to the resident.
A review of Resident 81's January 2025 Medication Administration Record (MAR) indicated a 4 (meaning
other, see nurse notes') with LVN D's initials in the 1/13/25 at 9 a.m. entry for lidocaine 5% patch.
A review of the nurse's notes, written on 1/13/2025 at 10:24 a.m. by LVN D, indicated: Lidocaine Patch 5 % .
On order Call the the pharmacy, MD and family aware. Will fallow up with pharmacy.
2. During a medication administration observation on 1/13/25 at 10:08 a.m., LVN E was observed preparing
8 medications, including a lidocaine 4% patch, for Resident 133.
On 1/13/25 at 10:26 a.m., at Resident 133's bedside, LVN E was observed removing a patch from the
resident's left upper shoulder and applying the newly-prepared lidocaine 4% patch on the same location.
During a concurrent interview and record review with LVN E on 1/13/25 at 10:30 a.m., she confirmed she
removed the previous day's lidocaine patch before applying a new one. When asked whether the used
patch should have been removed the night before, she reviewed Resident 133's clinical record and stated,
They didn't remove at 9 p.m. but they were supposed to remove it.
On 1/13/25 at 10:35 a.m., LVN E advised the surveyor, The resident refused to remove the patch.
A review of Resident 133's clinical record indicated a physician's order, dated 12/24/24, for Lidocaine Patch
4% Apply to Left Shoulder topically one time a day for pain management Apply at 9am and remove at 9 pm.
On 1/13/25, a review of the nursing progress notes, from 1/12 to 1/13/25, did not have any documentation
regarding the resident refusing for the previous day's patch to be removed at 9 p.m. on
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 15 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
1/12/25.
Level of Harm - Minimal harm
or potential for actual harm
On 1/13/25 at 2:35 p.m., an interview was conducted with Resident 133 at his bedside with LVN E present.
Resident 33 stated the staff had been applying the lidocaine patch daily in the morning and removing it at
night. LVN E asked the resident why the one from last night was not removed, Resident 133 stated, I don't
remember. LVN E asked whether he would be okay with them removing the patch tonight, he stated, Yeah,
ok. I don't have a problem with that.
Residents Affected - Some
3. During a medication administration observation with LVN F on 1/13/25 at 10:36 a.m., she was observed
preparing and administering 5 medications to Resident 118. Included in the medications was a tablet of
aspirin chewable 81 milligrams (mg, unit of measurement).
A review of Resident 118's clinical record indicated a physician's order for Aspirin EC [enteric coated - a
coating formation that allows aspirin to pass through the stomach to the small intestine before dissolving]
Low Dose Oral Tablet Delayed Release 81 mg Give 1 tablet by mouth one time a day for CVA ppx
[cerebrovascular accident or stroke prevention].
During a concurrent interview and record review with LVN F on 1/13/25 at 2:26 p.m., she reviewed Resident
118's physician's order for aspirin and confirmed she administered the chewable (or immediate release)
aspirin while the physician's order indicated for the enteric-coated, delayed release formulation.
A review of the facility's policy and procedures titled Administering Medications, revised April 2019,
indicated, Medications are administered in accordance with prescriber orders, including any required time
frame.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 16 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0812
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Procure food from sources approved or considered satisfactory and store, prepare, distribute and serve
food in accordance with professional standards.
Based on observation, interview, and record review, the facility failed to ensure food safety and sanitation
practices were maintained in the kitchen according to standards of practice and facility policy when two of
the ceiling exhaust fans above the food preparation area were dirty and dusty with grey lint.
These failures had the potential to cause food borne illness for 143 residents consuming food in the facility.
Findings:
During a kitchen tour observation on 1/13/25 at 1:58 p.m. two ceiling exhaust fans above the food
preparation area were observed dirty and dusty with grey lint.
During a concurrent observation and interview on 1/14/25 at 3:30 p.m., with the Maintenance Director
(MDR), the MDR used the ladder to reach the ceiling exhaust fan above the food preparation area and
wiped it, then he confirmed the dust. The MDR stated maintenance did the cleaning of the kitchen monthly.
During a concurrent observation and interview on 1/14/25 at 3:35 p.m., with Registered Dietitian H (RD H),
she confirmed two of ceiling exhaust fans above the food preparation area were dirty and dusty with grey
lint. She stated that the food preparation area should be clean. She further stated, they would clean it
before preparing the next meal.
During a review of the facility's P&P titled Sanitization, Care of Residents revise date, 11/2022 indicated, 1.
All kitchens, Kitchen areas and dining areas are kept clean, free from garbage and debris, and protected
from rodents and insects .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 17 of 18
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056212
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Redwoods Post-Acute
1267 Meridian Avenue
San Jose, CA 95125
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0814
Dispose of garbage and refuse properly.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility failed to ensure one of two trash dumpsters
had the lid closed completely.
Residents Affected - Some
This failure had the potential to attract pests (like flies and rodents) that could spread diseases and bacteria
to the 150 residents residing at the facility.
Findings:
During a concurrent observation and interview on 1/14/2025 at 3:24 p.m., with the Dietary Supervisor (DS),
the lid of one trash dumpster behind the kitchen was open and not closed completely flat. The DS stated,
that trash container lids should be closed completely.
During a concurrent observation and interview on 1/14/2025 at 3:28 p.m., with the Maintenance Director
(MDR), he confirmed, one of two trash dumpster's lid was not completely closed. The MDR stated all the
facility garbage goes to those trash dumpsters. He stated, trash dumpster lid should be closed.
During an interview on 1/16/2025 at 9:06 a.m., with the Infection Preventionist Nurse (IP), the IP stated that
the trash dumpsters should be fully closed and should have no space in between the lid to prevent any
animals from going in and to control the infection.
During a review of the facility's policies and procedures (P&P) titled, Food-Related Garbage and Refused
Disposal, Revised 10/2017, the P&P indicated . 2. All garbage and refuse containers are provided with
tight-fitting lid or covers and must be kept covered when stored or not in continuous use . 5. Garbage and
refuse containing food wastes will be stored in a manner that is inaccessible to pests .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056212
If continuation sheet
Page 18 of 18